Clinical trials
Phase 1/2 trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
972 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 10 |
| 2002 | 6 |
| 2003 | 14 |
| 2004 | 15 |
| 2005 | 32 |
| 2006 | 17 |
| 2007 | 22 |
| 2008 | 29 |
| 2009 | 29 |
| 2010 | 39 |
| 2011 | 28 |
| 2012 | 42 |
| 2013 | 33 |
| 2014 | 42 |
| 2015 | 64 |
| 2016 | 46 |
| 2017 | 51 |
| 2018 | 38 |
| 2019 | 49 |
| 2020 | 51 |
| 2021 | 57 |
| 2022 | 54 |
| 2023 | 50 |
| 2024 | 53 |
| 2025 | 51 |
| 2026 | 35 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 469 |
| Recruiting | 152 |
| Terminated | 137 |
| Active, not recruiting | 118 |
| Unknown status | 57 |
| Not yet recruiting | 15 |
| Withdrawn | 14 |
| Enrolling by invitation | 6 |
| Suspended | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 47 |
| University Health Network, Toronto | 40 |
| Novartis Pharmaceuticals | 34 |
| University of Alberta | 27 |
| GlaxoSmithKline | 25 |
| Merck Sharp & Dohme LLC | 22 |
| Hoffmann-La Roche | 20 |
| Pfizer | 19 |
| AstraZeneca | 18 |
| Sunnybrook Health Sciences Centre | 18 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 69 |
| Neoplasms | 62 |
| Breast Neoplasms | 52 |
| Recurrence | 39 |
| Colorectal Neoplasms | 38 |
| Multiple Myeloma | 38 |
| Prostatic Neoplasms | 34 |
| Neoplasm Metastasis | 31 |
| Lung Neoplasms | 30 |
| Lymphoma, Non-Hodgkin | 28 |
Trials
Showing 1 to 25 of 972. Each trial links to its page on Pharma Observatory.
872 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.